The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: Results of the randomised controlled phase 2 BELOB trial von Dirven, Linda, van den Bent, Martin J, Bottomley, Andrew, van der Meer, Nelly, van der Holt, Bronno, Vos, Maaike J, Walenkamp, Annemiek M.E, Beerepoot, Laurens V, Hanse, Monique C.J, Reijneveld, Jaap C, Otten, Aja, de Vos, Filip Y.F.L, Smits, Marion, Bromberg, Jacoline E.C, Taal, Walter, Taphoorn, Martin J.B

Volltext